Evidence map›Paper›PMID 22110751›Full record

ArticlePloS one2011

Inhibitory role of Notch1 in calcific aortic valve disease.

Asha Acharya, Chetan P Hans, Sara N Koenig, Haley A Nichols, Cristi L Galindo, Harold R Garner, Walter H Merrill, Robert B Hinton, Vidu Garg

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 113 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Midkine Prevents Calcification of Aortic Valve Interstitial CellsFrontiers in cell and developmental biology · 2021
    Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 1 country.

Asha AcharyaDepartment of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas, United States of America.
Chetan P Hans
Sara N Koenig
Haley A Nichols
Cristi L Galindo
Harold R Garner
Walter H Merrill
Robert B Hinton
Vidu Garg
The University of Texas Southwestern Medical Center · USNationwide Children's Hospital · USCincinnati Children's Hospital Medical Center · USThe Ohio State University · USUniversity of Cincinnati · USVirginia Tech · US

Funding

WRCE Nonhuman Primate CoreU54AI057156 · NIAID · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI WALKER, DAVID H · 2003 to 2013
$102.6M
Genetic Regulation of Cardiac SeptationR01HL088965 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI GARG, VIDU · 2007 to 2011
$1.9M
Genetic/Developmental Basis of Pediatric Aortic ValveK23HL085122 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI HINTON, ROBERT BRUCE · 2006 to 2010
$664k
NHLBI NIH HHS K23 HL085122NHLBI NIH HHS R01 HL088965NIAID NIH HHS U54 AI057156
6 · The paper itself

Abstract

Aortic valve calcification is the most common form of valvular heart disease, but the mechanisms of calcific aortic valve disease (CAVD) are unknown. NOTCH1 mutations are associated with aortic valve malformations and adult-onset calcification in families with inherited disease. The Notch signaling pathway is critical for multiple cell differentiation processes, but its role in the development of CAVD is not well understood. The aim of this study was to investigate the molecular changes that occur with inhibition of Notch signaling in the aortic valve. Notch signaling pathway members are expressed in adult aortic valve cusps, and examination of diseased human aortic valves revealed decreased expression of NOTCH1 in areas of calcium deposition. To identify downstream mediators of Notch1, we examined gene expression changes that occur with chemical inhibition of Notch signaling in rat aortic valve interstitial cells (AVICs). We found significant downregulation of Sox9 along with several cartilage-specific genes that were direct targets of the transcription factor, Sox9. Loss of Sox9 expression has been published to be associated with aortic valve calcification. Utilizing an in vitro porcine aortic valve calcification model system, inhibition of Notch activity resulted in accelerated calcification while stimulation of Notch signaling attenuated the calcific process. Finally, the addition of Sox9 was able to prevent the calcification of porcine AVICs that occurs with Notch inhibition. In conclusion, loss of Notch signaling contributes to aortic valve calcification via a Sox9-dependent mechanism.

Indexed as

AgedAged, 80 and overAnimalsAortic ValveCalcinosisCell Cycle ProteinsChlorocebus aethiopsCOS CellsExtracellular Matrix ProteinsGene Expression RegulationHeart Valve DiseasesHumansMiddle AgedProtein TransportRatsReceptor, Notch1Cell Cycle ProteinsExtracellular Matrix ProteinsReceptor, Notch1SOX9 Transcription Factor

Identifiers

PMID22110751
PMCPMC3218038
OpenAlexW2009968012

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.